NPR3促进结直肠癌细胞的增殖,迁移,入侵和耐化疗
Wensheng Chen1, Qingshui Wang2, Shuyuan Li3
1Department of General Surgery, Fujian Provincial Governmental Hospital, No. 67 Guping, Fuzhou 350122, Fujian, China.
Biochimica et biophysica acta. General subjects
|December 11, 2025
概括
一个新的基因特征预测结直肠癌 (CRC) 的存活率和转移. 性受体3 (NPR3) 驱动CRC进展和化学抵抗,为改善患者的治疗结果提供潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 淋巴结转移是结直肠癌 (CRC) 的关键预后因素.
- 识别与转移相关的关键基因可以改善风险分层和治疗策略.
研究的目的:
- 在CRC中识别与淋巴结转移相关的基因特征.
- 研究尿素受体3 (NPR3) 在CRC转移和化学抵抗中的作用.
主要方法:
- 具有和没有淋巴结转移的CRC组织的差异基因表达分析.
- 使用LASSO回归构建淋巴结转移相关基因特征 (LNMRGS).
- 在体外和体内实验,以调查NPR3.3的功能.
主要成果:
- 确定了包括ITGB3,IQCA1,ANGPTL4和NPR3在内的4个基因签名 (LNMRGS),预测了CRC的整体存活率.
- 高LNMRGS与先进的临床指标相关,包括远程转移和KRAS突变.
- 抑制NPR3 Knockdown抑制了CRC细胞的增殖,迁移,入侵,并减少了对5-FU和氧化的化学抵抗.
结论:
- LNMRGS作为结直肠癌的强有力的预后签名.
- NPR3涉及CRC转移性进展和化学抵抗,突出其作为治疗点的潜力.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.3K
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.4K
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
518
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
518
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
